MicroPort MedBot (2252.HK) Proposes New Directors, Amends Governance Documents, and Convenes EGM

Bulletin Express

11/06

Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) has announced plans to appoint six new directors and amend its corporate governance documents. The new directors include four non-executive candidates—namely, Dr. Chang Zhaohua, Mr. Hiroshi Shirafuji, Mr. Norihiro Ashida, and Ms. Liang Min—as well as two independent non-executive candidates, Mr. Jonathan H. Chou and Dr. Guoen Liu. Upon approval, the Board will expand from eight to eleven members.

The company has also proposed amendments to its Articles of Association and the Rules of Procedure for the General Meeting of Shareholders, aimed at optimizing Board composition and reflecting the new appointments. These amendments require shareholders’ approval.

An Extraordinary General Meeting (EGM) is scheduled for 25 November 2025 at 10:00 a.m. in Shanghai, where shareholders will vote on these matters. Shareholders registered by 19 November 2025 are eligible to attend. The relevant proxy documents and additional details are available in the company’s circular dated 5 November 2025.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1188629197"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1188629197\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1188629197?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 06:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188629197","market":"hk","top_or_hot":-1,"title":"MicroPort MedBot (2252.HK) Proposes New Directors, Amends Governance Documents, and Convenes EGM","media":"Bulletin Express","content":"<p>Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) has announced plans to appoint six new directors and amend its corporate governance documents. The new directors include four non-executive candidates—namely, Dr. Chang Zhaohua, Mr. Hiroshi Shirafuji, Mr. Norihiro Ashida, and Ms. Liang Min—as well as two independent non-executive candidates, Mr. Jonathan H. Chou and Dr. Guoen Liu. Upon approval, the Board will expand from eight to eleven members.</p>\n<p>The company has also proposed amendments to its Articles of Association and the Rules of Procedure for the General Meeting of Shareholders, aimed at optimizing Board composition and reflecting the new appointments. These amendments require shareholders’ approval.</p>\n<p>An Extraordinary General Meeting (EGM) is scheduled for 25 November 2025 at 10:00 a.m. in Shanghai, where shareholders will vote on these matters. Shareholders registered by 19 November 2025 are eligible to attend. The relevant proxy documents and additional details are available in the company’s circular dated 5 November 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroPort MedBot (2252.HK) Proposes New Directors, Amends Governance Documents, and Convenes EGM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroPort MedBot (2252.HK) Proposes New Directors, Amends Governance Documents, and Convenes EGM\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2025-11-06 06:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) has announced plans to appoint six new directors and amend its corporate governance documents. The new directors include four non-executive candidates—namely, Dr. Chang Zhaohua, Mr. Hiroshi Shirafuji, Mr. Norihiro Ashida, and Ms. Liang Min—as well as two independent non-executive candidates, Mr. Jonathan H. Chou and Dr. Guoen Liu. Upon approval, the Board will expand from eight to eleven members.</p>\n<p>The company has also proposed amendments to its Articles of Association and the Rules of Procedure for the General Meeting of Shareholders, aimed at optimizing Board composition and reflecting the new appointments. These amendments require shareholders’ approval.</p>\n<p>An Extraordinary General Meeting (EGM) is scheduled for 25 November 2025 at 10:00 a.m. in Shanghai, where shareholders will vote on these matters. Shareholders registered by 19 November 2025 are eligible to attend. The relevant proxy documents and additional details are available in the company’s circular dated 5 November 2025.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02252","symbol_name":"微創機器人-B","start_time":0,"source_url":"","article_id":"1188629197","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188629197","pubTimestamp":1762382667,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) has announced plans to appoint six new directors and amend its corporate governance documents. The new directors include four non-executive...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02252":"微创机器人-B"},"translate_title":"微创医疗机器人(2252.HK)提名新董事、修订管治文件、召开临时股东大会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1},"content_text":"Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) has announced plans to appoint six new directors and amend its corporate governance documents. The new directors include four non-executive candidates—namely, Dr. Chang Zhaohua, Mr. Hiroshi Shirafuji, Mr. Norihiro Ashida, and Ms. Liang Min—as well as two independent non-executive candidates, Mr. Jonathan H. Chou and Dr. Guoen Liu. Upon approval, the Board will expand from eight to eleven members.\nThe company has also proposed amendments to its Articles of Association and the Rules of Procedure for the General Meeting of Shareholders, aimed at optimizing Board composition and reflecting the new appointments. These amendments require shareholders’ approval.\nAn Extraordinary General Meeting (EGM) is scheduled for 25 November 2025 at 10:00 a.m. in Shanghai, where shareholders will vote on these matters. Shareholders registered by 19 November 2025 are eligible to attend. The relevant proxy documents and additional details are available in the company’s circular dated 5 November 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}